Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
54 hedge funds and large institutions have $179M invested in Tetraphase Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 7 closing their positions.
229% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 7
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
125% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 8
109% more capital invested
Capital invested by funds: $85.8M → $179M (+$93.2M)
38% more funds holding
Funds holding: 39 → 54 (+15)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.9M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$14.3M |
| 3 |
BC
Broadfin Capital
New York
|
+$4.77M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$3.22M |
| 5 |
Millennium Management
New York
|
+$3.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$2.36M |
| 2 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$1.27M |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$306K |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$201K |
| 5 |
LOM
Loeb Offshore Management
New York
|
-$155K |
TTPH Hedge Fund Activity: Q4 2013 in Review
54 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q4 2013, worth a combined $179M — up 109% from $85.8M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new TTPH positions and 7 closed out — a net gain of 16 holders — while 18 added to existing stakes and 8 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $20.9M. The largest seller was Jennison Associates, cutting an estimated $2.36M.
- 54 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q4 2013, up from 39 in Q3 2013.
- Funds reported $179M of Tetraphase Pharmaceuticals, Inc. stock for Q4 2013, up 109% quarter-over-quarter.
- 23 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q4 2013 and 7 closed out, a net change of +16 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q4 2013 was Wellington Management Group, an estimated $20.9M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q4 2013 was Jennison Associates, an estimated $2.36M sold.
Based on aggregated 13F filings for Q4 2013.